Results 11 to 20 of about 371,286 (285)

Neuroimaging-Based Brain Age Estimation: A Promising Personalized Biomarker in Neuropsychiatry

open access: yesJournal of Personalized Medicine, 2022
It is now possible to estimate an individual’s brain age via brain scans and machine-learning models. This validated technique has opened up new avenues for addressing clinical questions in neurology, and, in this review, we summarize the many clinical ...
Daichi Sone, I. Beheshti
semanticscholar   +1 more source

Postinfectious COVID-19 Catatonia: A Report of Two Cases

open access: yesFrontiers in Psychiatry, 2021
Neuropsychiatric symptoms are a common complication of COVID-19, with symptoms documented both during acute COVID-19 infection (parainfectious) and persisting or developing after the resolution of respiratory symptoms (postinfectious).
Tyler Torrico   +8 more
doaj   +1 more source

Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy

open access: yesCNS Spectrums, 2022
Psilocybin is a tryptamine alkaloid found in some mushrooms, especially those of the genus Psilocybe. Psilocybin has four metabolites including the pharmacologically active primary metabolite psilocin, which readily enters the systemic circulation.
S. Dodd   +6 more
semanticscholar   +1 more source

Integrating Armchair, Bench, and Bedside Research for Behavioral Neurology and Neuropsychiatry: Editorial

open access: yesBiomedicines, 2022
"To learning much inclined, who went to see the Elephant (though all of them were blind) that each by observation might satisfy the mind" [...].
Masaru Tanaka   +2 more
semanticscholar   +1 more source

Efficacy of serious exergames in improving neuropsychiatric symptoms in neurocognitive disorders: Results of the X‐TORP cluster randomized trial

open access: yesAlzheimer’s & Dementia: Translational Research & Clinical Interventions, 2021
Introduction The aim of this study was to evaluate the efficacy of a serious exergame in improving the neuropsychiatric symptoms of patients with neurocognitive disorders.
Philippe Robert   +11 more
doaj   +1 more source

Neurology and neuropsychiatry of COVID-19: a systematic review and meta-analysis of the early literature reveals frequent CNS manifestations and key emerging narratives

open access: yesJournal of Neurology Neurosurgery & Psychiatry, 2021
There is accumulating evidence of the neurological and neuropsychiatric features of infection with SARS-CoV-2. In this systematic review and meta-analysis, we aimed to describe the characteristics of the early literature and estimate point prevalences ...
Jonathan P. Rogers   +29 more
semanticscholar   +1 more source

Infra-low frequency neurofeedback in application to Tourette syndrome and other tic disorders: A clinical case series

open access: yesFrontiers in Human Neuroscience, 2022
We describe our clinical experience in treating patients with Tourette syndrome and other tic disorders using infra-low frequency neurofeedback (ILF NF), often in conjunction with cognitive behavior therapy.
Bodil Solberg, Erlend Solberg
doaj   +1 more source

Angelica gigas NAKAI and Its Active Compound, Decursin, Inhibit Cellular Injury as an Antioxidant by the Regulation of AMP-Activated Protein Kinase and YAP Signaling

open access: yesMolecules, 2022
Natural products and medicinal herbs have been used to treat various human diseases by regulating cellular functions and metabolic pathways.
Yu-Rim Song   +5 more
doaj   +1 more source

Factors Influencing the Total Functional Capacity Score as a Critical Endpoint in Huntington’s Disease Research

open access: yesBiomedicines, 2023
Background: The Total Functional Capacity (TFC) score is commonly used in Huntington’s disease (HD) research. The classification separates each disease stage (1–5), e.g., as an inclusion criterion or endpoint in clinical trials accepted by the Food and ...
Jannis Achenbach   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy